# A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.

> **NCT00207701** · PHASE3 · COMPLETED · sponsor: **Centocor, Inc.** · enrollment: 279 (actual)

## Conditions studied

- Ankylosing Spondylitis

## Interventions

- **DRUG:** infliximab

## Key facts

- **NCT ID:** NCT00207701
- **Lead sponsor:** Centocor, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** —
- **Final completion:** 2005-02
- **Target enrollment:** 279 (ACTUAL)
- **Last updated:** 2011-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00207701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00207701, "A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00207701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*